# Quantum-augmented graph differential geometry enhances accuracy in protein-protein interaction prediction

**Authors:** V. Karthick, Fahad Sameer Alshammari, I. Paulraj Jayasimman, P. Roselyn Besi, Ali Akgul

PMC · DOI: 10.1038/s41598-026-41325-5 · Scientific Reports · 2026-02-27

## TL;DR

This paper introduces a new quantum-based model that improves predictions of how proteins interact, leading to better accuracy and new discoveries in human protein networks.

## Contribution

The novel Quantum-based Graph Differential Model (QGDM) integrates quantum mechanics and differential geometry for enhanced PPI prediction.

## Key findings

- QGDM achieved 96.7% accuracy, outperforming existing methods by up to 15.2%.
- The model identified 1247 novel PPIs in the human interactome with 91.8% experimental validation accuracy.
- Quantum principles provided new insights into the probabilistic nature of protein interactions.

## Abstract

Protein-protein interactions (PPIs) constitute the fundamental building blocks of cellular machinery, orchestrating complex biological processes from signal transduction to metabolic regulation. Despite significant advances in computational biology, existing methods face critical limitations in capturing the quantum mechanical nature of molecular interactions and the intricate dynamics of protein networks. This work introduces a groundbreaking Quantum-based Graph Differential Model (QGDM) that synergistically combines quantum superposition principles with differential geometry to model PPI networks with unprecedented accuracy. Our innovative framework incorporates quantum state representations of protein conformations, quantum entanglement effects in binding sites, and novel differential operators on protein interaction graphs to capture temporal dynamics. Through comprehensive evaluation on five major datasets (STRING, BioGRID, IntAct, HIPPIE, and DIP), QGDM achieves exceptional performance with 96.7% accuracy, 95.8% precision, and 94.3% recall, representing improvements of 15.2%, 13.9%, and 16.1% respectively over state-of-the-art methods. Our model successfully identified 1247 novel PPIs in the human interactome, with experimental validation confirming 91.8% accuracy through yeast two-hybrid screening and co-immunoprecipitation assays. The quantum differential framework provides revolutionary insights into the probabilistic nature of protein interactions and establishes a theoretical foundation for understanding cellular network dynamics through quantum mechanical principles. This work opens new frontiers in computational biology, offering transformative capabilities for drug discovery, disease mechanism elucidation, and personalized medicine applications.

## Full-text entities

- **Genes:** MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PALB2 (partner and localizer of BRCA2) [NCBI Gene 79728] {aka BROVCA5, FANCN, PNCA3}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, PSEN2 (presenilin 2) [NCBI Gene 5664] {aka AD3L, AD4, CMD1V, PS2, STM2}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, PSEN1 (presenilin 1) [NCBI Gene 5663] {aka ACNINV3, AD3, CMD1U, FAD, PS-1, PS1}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, BRD4 (bromodomain containing 4) [NCBI Gene 23476] {aka CAP, CDLS6, FSHRG4, HUNK1, HUNKI, MCAP}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, MDM4 (MDM4 regulator of p53) [NCBI Gene 4194] {aka BMFS6, HDMX, MDMX, MRP1}
- **Diseases:** Cancer (MESH:D009369), Alzheimer's Disease (MESH:D000544), Neurological Disorder (MESH:D009461), BRCA-deficient cancers (MESH:D001943), Parkinson's Disease (MESH:D010300)
- **Chemicals:** Amino acid (MESH:D000596), Cholesterol (MESH:D002784), Hydrogen (MESH:D006859), Carbon (MESH:D002244), NADPH (MESH:D009249), Lipid (MESH:D008055), Pentose phosphate (MESH:D010428), TCA (MESH:D014238)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12979848/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12979848/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12979848/full.md

---
Source: https://tomesphere.com/paper/PMC12979848